hasMolecularTarget
P37016
predicate
Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
All labels observed (28)
| Label | Occurrences |
|---|---|
| targetOfDrug | 48 |
| hasMolecularTarget canonical | 28 |
| therapeuticTargetOf | 15 |
| isTargetOfDrug | 14 |
| drugTarget | 13 |
| hasPharmacologicTarget | 5 |
| isDrugTargetFor | 5 |
| isDrugTargetOf | 5 |
| isTherapeuticTargetOf | 5 |
| targetMolecule | 5 |
| drugTargetFor | 4 |
| molecularTarget | 4 |
| affectsMolecularTarget | 3 |
| hasMolecularTargetClass | 3 |
| hasMolecularTargetType | 3 |
| targetsEnzyme | 3 |
| isTargetOfDrugClass | 2 |
| ligandOf | 2 |
| targetsDrug | 2 |
| targetsMolecule | 2 |
| therapeuticTarget | 2 |
| biologicTarget | 1 |
| drugMechanismStudied | 1 |
| hasPharmacologicalTargetCell | 1 |
| hasPrimaryMolecularTarget | 1 |
| molecularTargetClass | 1 |
| pertuzumabTarget | 1 |
| trastuzumabTarget | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasMolecularTarget
Generated description
Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
Sample triples (180)
| Subject | Object |
|---|---|
| Ruxience | CD20-positive B lymphocytes via predicate surface "hasPharmacologicalTargetCell" ⓘ |
| CLEOPATRA trial | HER2 receptor via predicate surface "biologicTarget" ⓘ |
| APHINITY trial | HER2 receptor via predicate surface "drugTarget" ⓘ |
| Methane Sensor for Mars | methane via predicate surface "targetMolecule" ⓘ |
| Methane Sensor for Mars | CH4 via predicate surface "targetMolecule" ⓘ |
| CB2 receptor | anti-inflammatory agents via predicate surface "isDrugTargetFor" ⓘ |
| CB2 receptor | analgesic agents via predicate surface "isDrugTargetFor" ⓘ |
| CB2 receptor | immunomodulatory drugs via predicate surface "isDrugTargetFor" ⓘ |
| CB2 receptor | anti-fibrotic drugs via predicate surface "isDrugTargetFor" ⓘ |
| CB2 receptor | anti-osteoporotic drugs via predicate surface "isDrugTargetFor" ⓘ |
| Juno Therapeutics | CD19 via predicate surface "therapeuticTarget" ⓘ |
| Juno Therapeutics | BCMA via predicate surface "therapeuticTarget" ⓘ |
|
velpatasvir
surface form:
Velpatasvir
|
hepatitis C virus replication complex ⓘ |
|
Wolbachia bacteria
surface form:
Wolbachia
|
doxycycline via predicate surface "targetOfDrug" ⓘ |
| Givlaari | ALAS1 mRNA NERFINISHED ⓘ |
| Givlaari | aminolevulinate synthase 1 NERFINISHED ⓘ |
| Oxlumo | HAO1 gene product pathway ⓘ |
| Amvuttra | transthyretin NERFINISHED ⓘ |
| maftivimab | Ebola virus glycoprotein NERFINISHED ⓘ |
| maftivimab | Zaire ebolavirus glycoprotein ⓘ |
| odesivimab | Ebola virus glycoprotein ⓘ |
| ansuvimab | Ebola virus envelope glycoprotein GP1,2 ⓘ |
| Imfinzi | CD274 NERFINISHED ⓘ |
| Imfinzi | B7-H1 NERFINISHED ⓘ |
| L01BA04 | folate-dependent enzymes via predicate surface "molecularTargetClass" ⓘ |
| IL-17A | secukinumab via predicate surface "therapeuticTargetOf" NERFINISHED ⓘ |
| IL-17A | ixekizumab via predicate surface "therapeuticTargetOf" NERFINISHED ⓘ |
| IL-17A | netakimab via predicate surface "therapeuticTargetOf" NERFINISHED ⓘ |
| selpercatinib | receptor tyrosine kinase via predicate surface "hasMolecularTargetType" ⓘ |
| LOXO-292 | RET NERFINISHED ⓘ |
| LOXO-292 | RET fusions ⓘ |
| LOXO-292 | RET activating mutations ⓘ |
| Vitrakvi | tropomyosin receptor kinases ⓘ |
| JEWELFISH | SMN2 pre-mRNA splicing via predicate surface "drugTarget" ⓘ |
| RAINBOWFISH | increasing SMN protein levels via SMN2 splicing modification via predicate surface "drugMechanismStudied" ⓘ |
| Dupixent | interleukin-4 receptor alpha via predicate surface "targetsMolecule" NERFINISHED ⓘ |
| CDK6 | palbociclib via predicate surface "isDrugTargetOf" NERFINISHED ⓘ |
| CDK6 | ribociclib via predicate surface "isDrugTargetOf" ⓘ |
| CDK6 | abemaciclib via predicate surface "isDrugTargetOf" NERFINISHED ⓘ |
| CDK6 | trilaciclib via predicate surface "isDrugTargetOf" NERFINISHED ⓘ |
| CDK6 | dalpiciclib via predicate surface "isDrugTargetOf" NERFINISHED ⓘ |
| branaplam | SMN2 pre-mRNA splicing via predicate surface "molecularTarget" ⓘ |
| Kevzara | IL6R NERFINISHED ⓘ |
| bapineuzumab | extracellular amyloid beta plaques ⓘ |
| Gleevec | oncogenic fusion protein via predicate surface "hasMolecularTargetType" ⓘ |
| Gleevec | BCR-ABL1 fusion protein via predicate surface "hasPrimaryMolecularTarget" NERFINISHED ⓘ |
| Kymriah | CD19 via predicate surface "molecularTarget" NERFINISHED ⓘ |
| GABA | barbiturates via predicate surface "isTargetOfDrugClass" ⓘ |
| GABA | gabapentinoids via predicate surface "isTargetOfDrugClass" ⓘ |
| HIV-1 | reverse transcriptase via predicate surface "drugTarget" ⓘ |